Literature DB >> 29746421

Reducing the health risks derived from exposure to addictive substances.

Peter Anderson1,2, Antoni Gual3,4,5,6, Jürgen Rehm7,8,9.   

Abstract

PURPOSE OF REVIEW: To discuss the health risks due to exposure to alcohol, illegal drugs and nicotine and how these risks might be reduced. RECENT
FINDINGS: In 2016, worldwide, alcohol, illegal drugs and nicotine were responsible for some 10 million deaths. There is evolutionary and biological evidence that humans are predisposed to consuming alcohol, illegal drugs and nicotine - present-day problems are caused by high levels of potency, exposure and drug delivery systems. The two priority substances for action are alcohol and smoked cigarettes; their exposure can be reduced by price increases, setting minimum prices per product, regulating a shift form smoked cigarettes to electronic nicotine delivery devices and, theoretically, reducing the ethanol content of existing beverages. Legalization of cannabis requires a strict regulatory framework.
SUMMARY: Purposeful policy can reduce the harm done by alcohol, illegal drugs and nicotine. In particular, policy to reduce exposure to alcohol requires considerable strengthening.

Entities:  

Mesh:

Year:  2018        PMID: 29746421     DOI: 10.1097/YCO.0000000000000432

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  2 in total

1.  Regulatory Policies for Alcohol, other Psychoactive Substances and Addictive Behaviours: The Role of Level of Use and Potency. A Systematic Review.

Authors:  Jürgen Rehm; Jean-François Crépault; Omer S M Hasan; Dirk W Lachenmeier; Robin Room; Bundit Sornpaisarn
Journal:  Int J Environ Res Public Health       Date:  2019-10-04       Impact factor: 3.390

2.  Comments from the Editors on the Special Issue "Assessment and Treatment of Addictions: New Tools for Old Problems".

Authors:  Pablo Barrio; Laia Miquel; Antoni Gual
Journal:  J Clin Med       Date:  2019-10-17       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.